Lurasidon Teva 37 mg filmom obložene tablete
| Name | Lurasidon Teva 37 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-884934101 |
| Active Substance | lurasidonklorid |
| Composition | jedna filmom obložena tableta sadrži lurasidonklorid što odgovara 37,2 mg lurasidona |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska
Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 13.06.2024 |
| MA Period of Validity | 13.06.2029 |
| Classification Number | UP/I-530-09/23-01/103 |
| Registration Number | 381-12-01/171-24-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N05AE05 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
